IP Library › Granted Patent US 11,607,307
Granted Patent B2
US 11,607,307 · App. 17/457,360 · Granted Mar 21, 2023

Prosthetic capsular devices, systems, and methods

Inventor: Gary N. Wortz (Nicholasville, KY)
Assignee: Omega Ophthalmics LLC
A61F2/14A61F2/1648A61F2/1694A61F2/16A61F2/1662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,607,307
App. No.
17/457,360
Granted
Mar 21, 2023
Kind
B2
Abstract

The present invention relates to a prosthetic capsular bag and method for inserting the same. The prosthetic capsular bag helps to maintain the volume of the natural capsular bag, thereby stabilizing the effective lens position of an IOL so that refractive outcomes may be improved with cataract surgery. The prosthetic capsular bag further provides an integrated refractive surface, providing a means for experimentally determining an effective lens position prior to inserting an IOL.

Claims (28)

1. A prosthetic implant device for insertion into a natural capsular bag of an eye after removal of a cataract, wherein the prosthetic implant device comprises:

an anterior side including an opening;

a posterior side; and

a deformable sidewall between the anterior side and the posterior side,

wherein the prosthetic implant device is configured to mechanically maintain substantially a volume of the natural capsular bag,

wherein the prosthetic implant device is configured to self-expand to maintain substantially the volume of the natural capsular bag,

wherein the prosthetic implant device is adapted to contain an intraocular lens,

wherein the prosthetic implant device has sufficient elasticity to resume a pre-folded shape once positioned in the eye, and

wherein the deformable sidewall forms a single continuous wall from the anterior side to the posterior side.

2. The prosthetic implant device of claim 1 , wherein the prosthetic implant device comprises a biologically compatible material.

3. The prosthetic implant device of claim 1 , wherein the prosthetic implant device comprises an optically clear material.

4. The prosthetic implant device of claim 1 , wherein the prosthetic implant device comprises at least one of the following materials:

collamer and acrylic.

5. The prosthetic implant device of claim 1 , wherein the prosthetic implant device is foldable.

6. The prosthetic implant device of claim 1 , wherein the intraocular lens is configured to be placed in physical contact with a peripheral internal surface of the deformable sidewall.

7. The prosthetic implant device of claim 1 , the intraocular lens comprises a refractive surface.

8. The prosthetic implant device of claim 1 , wherein the intraocular lens includes at least one or more of the following characteristics: concave, convex, spherical, aspheric, wavefront, multifocal diffractive, multifocal refractive, multifocal zonal, accommodative, UV filtering, diffractive chromatic aberration reducing, and astigmatism correcting toric form.

9. The prosthetic implant device of claim 1 , wherein a portion of the prosthetic implant device is adapted to lie within the natural capsular bag and is shaped such that an exterior contour of the ophthalmic implant device conforms to a shape of the natural capsular bag.

10. The prosthetic implant device of claim 9 , wherein the exterior contour is adapted to mechanically maintain the prosthetic implant device at a specific position and orientation within the eye.

11. The prosthetic implant device of claim 1 , wherein the prosthetic implant device is substantially discoid in shape.

12. The prosthetic implant device of claim 1 , wherein the prosthetic implant device is approximately the size, shape, and volume of a natural human lens.

13. The prosthetic implant device of claim 1 , wherein the opening is configured to be open when the prosthetic implant device is inserted in the eye.

14. The prosthetic implant device of claim 1 , wherein the prosthetic implant device comprises a prosthetic barrier separating an anterior segment and posterior segment of the eye.

15. The prosthetic implant device of claim 1 , wherein the prosthetic implant device configured to receive pharmaceuticals for delivery to the eye.

16. The prosthetic implant device of claim 1 , wherein the prosthetic implant device is configured to enable a future lens exchange of the intraocular lenses.

17. The prosthetic implant device of claim 1 , wherein the intraocular lens comprises one or more haptics.

18. The prosthetic implant device of claim 17 , wherein the one or more haptics are configured to physically contact a peripheral internal surface of the deformable sidewall.

19. The prosthetic implant device of claim 1 , wherein the intraocular lens is between −30 diopters and +30 diopters.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2023
From: WORTZ, GARY N.
To: BLUEGRASS EYE SURGERY, PSC
Reel/Frame 062680/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2023
From: BLUEGRASS EYE SURGERY, PSC
To: OMEGA OPHTHALMICS LLC
Reel/Frame 062680/0105 →
Continuity (5)
Continuation 17037271 · Sep 29, 2020
Continuation 16135806 · Sep 19, 2018
Continuation 14551544 · Nov 24, 2014
Continuation 13402398 · Feb 22, 2012
Related Publication 20220183816A1 · Jun 16, 2022
Cited By (2)
US 12,186,179 US 12,290,434